Syncordia has operations in North America and Europe, and is focused on investing in, partnering with and growing RCM companies where proprietary technology can be used as an accelerator. Syncordia addresses a great void in niche healthcare sectors, such as EMS and behavioural health, where the necessary workflow/production/analytic components are largely absent or inadequate for a RCM company to maintain quality with scale. Syncordia is actively acquiring medical billing companies with and without proprietary software and building a proprietary suite of RCM software solutions called Platform Syncordia, which includes patient scheduling, electronic health records, claims management, analytics and more.
Syncordia’s ability to not only offer but control the entire product offering of both software and solutions uniquely positions the company to be able to deliver a refreshingly simple and powerful product offering that’s largely absent in healthcare today. Led by a team of executives with extensive experience in RCM and technology, acquisition opportunities are carefully selected to become part of the Syncordia family and enable Syncordia’s vision of becoming a world class technology enhanced RCM Company with best in class solutions.SYN 0.240 -0.040 -14.29%